WallStreetZenWallStreetZen

NASDAQ: DARE
Dare Bioscience Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DARE past revenue growth

How has DARE's revenue growth performed historically?
Company
-71.92%
Industry
148.97%
Market
17.57%
DARE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DARE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

DARE earnings and revenue history

Current Revenue
$2.8M
Current Earnings
-$30.2M
Current Profit Margin
-1,074.2%

DARE Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when DARE announces earnings.

DARE Return on Assets

Current Company
-120.8%
Current Industry
2.9%
DARE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DARE Return on Capital Employed

Current Company
-3,761.81%
Current Industry
19.5%
DARE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DARE vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DARE$2.81M-$30.07M-$30.16M-71.92%N/A
ACXP$0.00-$14.58M-$14.58MN/AN/A
LPCN-$2.85M-$16.32M-$16.35MN/AN/A
SPRB$10.09M-$47.14M-$47.92MN/AN/A
ENLV$0.00-$28.56M-$29.07MN/AN/A
View Top Biotech Stocks

DARE earnings dates

Next earnings date
May 9, 2024

Dare Bioscience Earnings & Revenue FAQ

What were DARE's earnings last quarter?

On Invalid Date, Dare Bioscience (NASDAQ: DARE) reported Q4 2023 earnings per share (EPS) of -$0.06, up 68.42% year over year. Total Dare Bioscience earnings for the quarter were -$5.06 million. In the same quarter last year, Dare Bioscience's earnings per share (EPS) was -$0.19.

If you're new to stock investing, here's how to buy Dare Bioscience stock.

What was DARE's earnings growth in the past year?

As of Q2 2024, Dare Bioscience's earnings has grown year over year. Dare Bioscience's earnings in the past year totalled -$30.16 million.

What is DARE's earnings date?

Dare Bioscience's earnings date is Invalid Date. Add DARE to your watchlist to be reminded of DARE's next earnings announcement.

What was DARE's revenue last quarter?

On Invalid Date, Dare Bioscience (NASDAQ: DARE) reported Q4 2023 revenue of $1.81 million up Infinity% year over year. In the same quarter last year, Dare Bioscience's revenue was $0.00.

What was DARE's revenue growth in the past year?

As of Q2 2024, Dare Bioscience's revenue has grown -71.92% year over year. This is 220.89 percentage points lower than the US Biotechnology industry revenue growth rate of 148.97%. Dare Bioscience's revenue in the past year totalled $2.81 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.